An Immunomodulatory Zinc‐Alum/Ovalbumin Nanovaccine Boosts Cancer Metalloimmunotherapy Through Erythrocyte‐Assisted Cascade Immune Activation
Advanced Science · 2024
DOI: 10.1002/advs.202307389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Jing Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutics, Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, P. …. Hauptthemen laut MEDLINE: Neoplasms, Cancer Vaccines, Alum Compounds. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Leading Talent of "Ten Thousand Plan"-National High-Level Talents Special Support Plan, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer therapeutic vaccines are powerful tools for immune system activation and eliciting protective responses against tumors. However, their efficacy has often been hindered by weak and slow immune responses. Here, the authors introduce an immunization strategy employing senescent erythrocytes to facilitate the accumulation of immunomodulatory zinc‐Alum/ovalbumin (ZAlum/OVA) nanovaccines within both the spleen and solid tumors by temporarily saturating liver macrophages. This approach sets the stage for boosted cancer metalloimmunotherapy through a cascade immune activation. The accumulation of ZAlum/OVA nanovaccines in the spleen substantially enhances autophagy‐dependent antigen presentation in dendritic cells, rapidly initiating OVA‐specific T‐cell responses against solid tumors. Concurrently, ZAlum/OVA nanovaccines accumulated in the tumor microenvironment trigger immunogenic cell death, leading to the induction of individualized tumor‐associated antigen‐specific T cell responses and increased T cell infiltration. This erythrocyte‐assisted cascade immune activation using ZAlum/OVA nanovaccines results in rapid and robust antitumor immunity induction, holding great potential for clinical cancer metalloimmunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutics, Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, P. R. China.
- Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, C DK-8000, Denmark.
- Frontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, School of Biomedical Engineering, National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai,…
- World Laureates Association (WLA) Laboratories, Shanghai, 201203, P. R. China.
- Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, 310009, P. R. China.
ORCID-Profile: Daishun Ling
Förderung
- National Key Research and Development Program of China
- Leading Talent of "Ten Thousand Plan"-National High-Level Talents Special Support Plan
- National Natural Science Foundation of China
- European Union's Research and Innovation Program under the Marie Skłodowska-Curie Grant Agreement
- Program of Shanghai Academic Research Leader under the Science and Technology Innovation Action Plan
- Explorer Program of Science and Technology Commission of Shanghai Municipality
- Zhejiang Provincial Natural Science Foundation of China
- CAS Interdisciplinary Innovation Team
Zitieren
APA
Zhao, J., Zhang, L., Li, P., Liu, S., Yu, S., Chen, Z., Zhu, M., Xie, S., Ling, D., & Li, F. (2024). An Immunomodulatory Zinc‐Alum/Ovalbumin Nanovaccine Boosts Cancer Metalloimmunotherapy Through Erythrocyte‐Assisted Cascade Immune Activation. Advanced Science. https://doi.org/10.1002/advs.202307389
Vancouver
Zhao J, Zhang L, Li P, Liu S, Yu S, Chen Z, et al. An Immunomodulatory Zinc‐Alum/Ovalbumin Nanovaccine Boosts Cancer Metalloimmunotherapy Through Erythrocyte‐Assisted Cascade Immune Activation. Advanced Science. 2024. doi:10.1002/advs.202307389
BibTeX
@article{Zhao2024,
author = {Zhao, Jing and Zhang, Lingxiao and Li, Pin and Liu, Shanbiao and Yu, Shiyi and Chen, Zheng and Zhu, Mingjian and Xie, Shangzhi and Ling, Daishun and Li, Fangyuan},
title = {An Immunomodulatory Zinc‐Alum/Ovalbumin Nanovaccine Boosts Cancer Metalloimmunotherapy Through Erythrocyte‐Assisted Cascade Immune Activation},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202307389}
}
EUVIMED